Escolha um dos esquemas.
Esquema A: Tratamento tópico (1
a
linha na maioria dos casos):
Associação:
I.
Xampu antifúngico.
+
II.
Outro
antifúngico.
Recorrência de pitiríase versicolor: você sabe como tratar?
Autoria principal: Jaqueline Barbeito de Vasconcellos (Dermatologia).
Veraldi S, Aromolo IF, Germiniasi FS, et al. Erythrasmoid pityriasis versicolor: three case reports and review of the literature. Dermatology Reports. 2025; 17: 9976.
Gold JAW, Benedict K, Lipner SR. Pityriasis versicolor epidemiology, disease predictors, and health care utilization: Analysis of 32,679 cases in a large commercial insurance database. J Am Acad Dermatol. 2025; 92(2): 316-319.
Deoghare S, Dodeja A. Erythematous variant of inverse pityriasis versicolor in skin of colour. Skin Health and Disease. 2025; 5: 90-91.
Vishwanath T, Kapadia FM, Mahajan SA, et al. Dermoscopic perspective of pityriasis versicolor in a cross‑sectional study. Indian Dermatol Online J. 2024; 15: 218-25.
Dsouza PA, Monteiro RC, Dias M, et al. Beyond the Surface: Decoding Pityriasis Versicolor Through Clinical, Dermoscopic and Microbiological Exploration. Indian J Dermatol. 2024; 70(1):6-10.
Genuino RNF, Dofitas BL, Batac MCF, et al. Systematic Review and Meta-analysis on Synthetic Antifungal versus Keratolytic Agents for Topical Treatment of Pityriasis Versicolor. Acta Medica Philippina. 2024; 58 (1):64-78.
Veasey JV, Carvalho GSM, Camargo G, et al. Oral isotretinoin for the treatment of chronic pityriasis versicolor: case report and literature review. Anais Brasileiros de Dermatologia. 2024; 99(4):635-649.
Alchorne MMA, Conceição KC, Barraza LL, et al. Dermatology in black skin. Anais Brasileiros de Dermatologia. 2024; 99(3):327-341.
Rao M, Young K, Jackson-Cowan L, et al. Post-Inflammatory Hypopigmentation: Review of the Etiology, Clinical Manifestations, and Treatment Options. J. Clin. Med. 2023; 12:1243.
Wang L, Xing H. Pityriasis versicolor on the scalp: An unusual distribution of a common disease. Pediatr Investig. 2023; 7:216-217.
Łabędź N, Navarrete-Dechent C, Kubisiak-Rzepczyk H, et al. Pityriasis Versicolor – A Narrative Review on the Diagnosis and Management.Life (Basel). 2023; 13(10):2097.
Leung AK, Barankin B, Lam JM, et al. Tinea versicolor: an updated review.Drugs Context. 2022; 11:2022-9-2.
Kaliyadan F, Ashique KT, Jayasree P. Increased incidence of facial pityriasis versicolor in children during the COVID-19 pandemic-A consequence of mask usage? Pediatr Dermatol. 2022; 39(5):834-5.
Saraswat N, Kumar S, Tripathy DM, et al. Pityriasis versicolor with 'deck chair' sign. Indian J Dermatol. 2022; 67(5):627.
Saunte DML, Gaitanis G, Hay RJ.
Malassezia
-associated skin diseases, the use of diagnostics and treatment.Front Cell Infect Microbiol. 2020; 10:112.
Gusso G, Lopes JMC. Tratado de medicina de família e comunidade. 2. ed. Porto Alegre: Artmed; 2019.
Mathur M, Acharya P, Karki A, et al. Dermoscopic pattern of pityriasis versicolor. Clin Cosmet Investig Dermatol. 2019; 12: 303-9.
Hudson A, Sturgeon A, Peiris A. Tinea versicolor. JAMA. 2018; 320(13):1396.
Renati S, Cukras A, Bigby M. Pityriasis versicolor. BMJ. 2015; 350:h1394.
Jubert E, Martín-Santiago A, Bernardino M, et al. Neonatal pityriasis versicolor. Pediatr Infect Dis J. 2015; 34(3):329-30.
Gupta AK, Foley KA. Antifungal treatment for pityriasis versicolor. J Fungi (Basel). 2015; 1(1):13-29.
Bolognia JL, Jorizzo JL, Schaffer JV, et al. Dermatologia. 3. ed. Rio de Janeiro: Elsevier; 2015.